These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3275847)

  • 1. Neoadjuvant chemotherapy for invasive bladder carcinoma.
    Fair WR
    Mayo Clin Proc; 1988 Jan; 63(1):86-7. PubMed ID: 3275847
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic management of invasive bladder carcinoma.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N; Geller N
    Eur Urol; 1988; 14 Suppl 1():19-20. PubMed ID: 3053199
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
    Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
    Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporation of M-VAC combination chemotherapy in the treatment of patients with invasive and metastatic bladder cancer.
    Soloway MS
    Eur Urol; 1988; 14 Suppl 1():42. PubMed ID: 3181242
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy in transitional-cell carcinoma of the bladder.
    McLaren DB
    Clin Oncol (R Coll Radiol); 2005 Oct; 17(7):503-7. PubMed ID: 16238137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy and bladder cancer.
    Garnick MB
    J Urol; 1989 Jan; 141(1):107. PubMed ID: 2642307
    [No Abstract]   [Full Text] [Related]  

  • 8. M-VAC chemotherapy in the management of locally advanced bladder cancer.
    Skinner DG
    J Urol; 1988 Mar; 139(3):570. PubMed ID: 3343745
    [No Abstract]   [Full Text] [Related]  

  • 9. Bladder-sparing approach in the treatment of invasive bladder cancer.
    Wajsman Z; Marino R; Parsons J; Oblon D; McCarley D
    Semin Urol; 1990 Aug; 8(3):210-5. PubMed ID: 2119051
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible alternative treatment for advanced transitional cell carcinoma of the urothelium (N+ and/or M+) in 1988.
    Perrin P; Mouriquand P; Monsallier M; Devonec M
    Prog Clin Biol Res; 1989; 303():617-9. PubMed ID: 2780666
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 12. MVAC for bladder cancer: time to move forward again.
    Levine EG; Raghavan D
    J Clin Oncol; 1993 Mar; 11(3):387-9. PubMed ID: 8445412
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery.
    Herr HW; Whitmore WF; Morse MJ; Sogani PC; Russo P; Fair WR
    J Urol; 1990 Nov; 144(5):1083-8. PubMed ID: 2231876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
    Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
    Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
    [No Abstract]   [Full Text] [Related]  

  • 15. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
    Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 17. Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder.
    Benson MC
    Ann Oncol; 1999 Nov; 10(11):1269-70. PubMed ID: 10631452
    [No Abstract]   [Full Text] [Related]  

  • 18. Bladder cancer chemotherapy: is response of squamous tumours different to that of transitional cell tumours?
    Oliver RT
    Ann Oncol; 1991 Feb; 2(2):87-8. PubMed ID: 1711366
    [No Abstract]   [Full Text] [Related]  

  • 19. Second-line chemotherapy in advanced bladder cancer.
    Pavone-Macaluso M; Sternberg C
    Urol Int; 2000; 64(2):61-9. PubMed ID: 10810266
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.